Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Arndt Vogel, Prof. Dr."
2
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT05101629
Completed
Phase 2
Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
ClinicalTrials.gov · CTIS (EMA)
NCT05101629
Completed
Phase 2
Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to...
Institut für Klinische Kr...
NCT06178445
Active Not Recruiting
Phase 2
Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
ClinicalTrials.gov · CTIS (EMA)
NCT06178445
Active Not Recruiting
Phase 2
Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously...
Institut für Klinische Kr...
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease